Verne Bio

Verne Bio is a biotech company founded in 2020 and is focused on developing quick, scalable genetic and pathogen testing for the Cannabis Market. Their slogan "A biotech company focused on developing quick, scalable genetic and pathogen testing for the Cannabis Market." encapsulates their mission. The company offers a range of testing services including Full Cannabis 16 Pathogens Panel, Cannabis-Focused Virus/Viroid Panel, Cannabis-Focused Fungal Panel, Cannabis-Focused Fusarium Panel, Cannabis-Focused Powdery Mildew Panel, Cannabis-Focused Botrytis Panel, Cannabis-Focused Pythium Panel, Sex Detection, and THCa. This includes outsourcing IPM and delivering quick results through testing, which can be conducted either in their lab or at home. Verne Bio operates in the AI, Biotechnology, and AgriTech industries, a sector that has been gaining significant attention from venture capital funds due to its potential to disrupt traditional agricultural practices and improve crop yields. While specific details regarding their venture capital funding and investors are not currently available, their focus on a niche market such as the cannabis industry and their innovative approach to genetic and pathogen testing make them a potential standout candidate for investment in the biotech sector. With the expanding interest in biotechnology and agricultural technology, Verne Bio's unique offerings and potential for growth in a burgeoning market may present an attractive opportunity for venture capital firms seeking to tap into this evolving industry.